Compounds > fludarabine

fludarabine and Enlarged Spleen

fludarabine has been researched along with Enlarged Spleen in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ben-Bassat, I; Bonstein, L; Gafter-Gvili, A; Raanani, P; Ram, R; Shpilberg, O1
Ascaso, FJ; Fuertes, MA; Jimenez, B; Keane, PA; Sadda, S1
Glasmacher, A; Gorschlüter, M; Mey, U; Pralle, H; Schmidt-Wolf, I; Strehl, J; Ziske, C1
Stiefelhagen, P1
Bradlow, BA; Chen, YH; Devine, SM; Hoffman, R; Huml, M; Jessop, E; Maynard, V; Peace, D; Shah, R; Stock, W; Thomason, D; van Besien, K; Verma, A1

Reviews

2 review(s) available for fludarabine and Enlarged Spleen

ArticleYear
Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
    American journal of hematology, 2009, Volume: 84, Issue:4

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Complement Activation; Complement System Proteins; Cyclophosphamide; Cytokines; Drug Eruptions; Female; Fever; Humans; Leukopenia; Lymphoma, Mantle-Cell; Mitoxantrone; Risk Factors; Rituximab; Splenomegaly; Thrombocytopenia; Vidarabine

2009
Advances in the treatment of hairy-cell leukaemia.
    The Lancet. Oncology, 2003, Volume: 4, Issue:2

    Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Cell Adhesion Molecules; Cladribine; Humans; Interferon-alpha; Lectins; Leukemia, Hairy Cell; Neoplasm, Residual; Neoplasms, Second Primary; Pancytopenia; Pentostatin; Receptors, Interleukin-2; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Spleen; Splenectomy; Splenomegaly; Treatment Outcome; Vidarabine

2003

Trials

1 trial(s) available for fludarabine and Enlarged Spleen

ArticleYear
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
    Blood, 2002, Mar-15, Volume: 99, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Melphalan; Middle Aged; Primary Myelofibrosis; Splenomegaly; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2002

Other Studies

2 other study(ies) available for fludarabine and Enlarged Spleen

ArticleYear
Diagnostic and therapeutic challenges.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:5

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Lymph Nodes; Male; Middle Aged; Retinal Neoplasms; Rituximab; Splenomegaly; Tomography, X-Ray Computed; Vidarabine; Vision, Low; Visual Acuity; Vitreoretinopathy, Proliferative; Vitreous Hemorrhage

2011
[Pressure pain in the left epigastrium: blood picture provides diagnosis. Chronic lymphatic leukemia].
    MMW Fortschritte der Medizin, 2003, Sep-25, Volume: 145, Issue:39

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambucil; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytosis; Lymphocyte Count; Male; Middle Aged; Prednisone; Splenomegaly; Time Factors; Ultrasonography; Vidarabine

2003